Beta-glucan contamination of pharmaceutical products: How much should we accept? (2016)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00262-016-1875-9
PubMed Identifier: 27473075
Publication URI: http://europepmc.org/abstract/MED/27473075
Type: Journal Article/Review
Volume: 65
Parent Publication: Cancer immunology, immunotherapy : CII
Issue: 11
ISSN: 0340-7004